International Patent: BASE COMPOSITION FOR TRANSEPITHELIAL DELIVERY OF NUCLEIC ACIDS, AND METHODS OF PRODUCING AND USING THE SAME

GENEVA, Nov. 6 -- TME THERAPEUTICS INC. filed a patent application (JP2025/016251) for “BASE COMPOSITION FOR TRANSEPITHELIAL DELIVERY OF NUCLEIC ACIDS, AND METHODS OF PRODUCING AND USING THE SAME”. With publication no. WO/2026/230033, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/44

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....